140 related articles for article (PubMed ID: 16927525)
21. Biological effects of natural and recombinant mistletoe lectin and an aqueous mistletoe extract on human monocytes and lymphocytes in vitro.
Elsässer-Beile U; Voss M; Schühle R; Wetterauer U
J Clin Lab Anal; 2000; 14(6):255-9. PubMed ID: 11138605
[TBL] [Abstract][Full Text] [Related]
22. Investigation of the effect of mistletoe (Viscum album L.) extract Iscador on the proliferation and apoptosis of murine thymocytes.
Hajtò T; Berki T; Pàlinkàs L; Boldizsàr F; Németh P
Arzneimittelforschung; 2006 Jun; 56(6A):441-6. PubMed ID: 16927524
[TBL] [Abstract][Full Text] [Related]
23. Mistletoe extract-induced effects on immunocompetent cells: in vitro studies.
Stein GM; Berg PA
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S39-42. PubMed ID: 9179366
[TBL] [Abstract][Full Text] [Related]
24. Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro.
Maier G; Fiebig HH
Anticancer Drugs; 2002 Apr; 13(4):373-9. PubMed ID: 11984083
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Viscum album QuFrF extract with vincristine in an in vitro model of human B cell lymphoma WSU-1.
Kovacs E; Link S; Toffol-Schmidt U
Arzneimittelforschung; 2008; 58(11):592-7. PubMed ID: 19137911
[TBL] [Abstract][Full Text] [Related]
26. Effects of Korean mistletoe lectin (Viscum album coloratum) on proliferation and cytokine expression in human peripheral blood mononuclear cells and T-lymphocytes.
Lyu SY; Park WB
Arch Pharm Res; 2007 Oct; 30(10):1252-64. PubMed ID: 18038904
[TBL] [Abstract][Full Text] [Related]
27. Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador.
Urech K; Schaller G; Jäggy C
Arzneimittelforschung; 2006 Jun; 56(6A):428-34. PubMed ID: 16927522
[TBL] [Abstract][Full Text] [Related]
28. Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro.
Estko M; Baumgartner S; Urech K; Kunz M; Regueiro U; Heusser P; Weissenstein U
BMC Complement Altern Med; 2015 Apr; 15():130. PubMed ID: 25902944
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of IL-12 and the production of IFN-gamma, IL-2 and IL-4 by peripheral blood mononuclear cells (PBMC) in cancer patients treated with Viscum album extract.
Kovacs E
Biomed Pharmacother; 2000 Jul; 54(6):305-10. PubMed ID: 10989963
[TBL] [Abstract][Full Text] [Related]
30. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.
Ribéreau-Gayon G; Jung ML; Frantz M; Anton R
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S3-8. PubMed ID: 9179359
[TBL] [Abstract][Full Text] [Related]
31. A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells.
Hostanska K; Hajto T; Spagnoli GC; Fischer J; Lentzen H; Herrmann R
Nat Immun; 1995 Sep; 14(5-6):295-304. PubMed ID: 8933823
[TBL] [Abstract][Full Text] [Related]
32. Preclinical investigations with mistletoe (Viscum album L.) extract Iscador.
Maldacker J
Arzneimittelforschung; 2006 Jun; 56(6A):497-507. PubMed ID: 16927531
[TBL] [Abstract][Full Text] [Related]
33. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
Grossarth-Maticek R; Ziegler R
Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms underlying the immunomodulatory effects of mistletoe (Viscum album L.) extracts Iscador.
Elluru S; Duong Van Huyen JP; Delignat S; Prost F; Bayry J; Kazatchkine MD; Kaveri SV
Arzneimittelforschung; 2006 Jun; 56(6A):461-6. PubMed ID: 16927527
[TBL] [Abstract][Full Text] [Related]
35. Influence of polysaccharides from Viscum album L. on human lymphocytes, monocytes and granulocytes in vitro.
Stein GM; Edlund U; Pfüller U; Büssing A; Schietzel M
Anticancer Res; 1999; 19(5B):3907-14. PubMed ID: 10628330
[TBL] [Abstract][Full Text] [Related]
36. Hypereosinophilia induced by high-dose intratumoral and peritumoral mistletoe application to a patient with pancreatic carcinoma.
Huber R; Barth H; Schmitt-Gräff A; Klein R
J Altern Complement Med; 2000 Aug; 6(4):305-10. PubMed ID: 10976976
[TBL] [Abstract][Full Text] [Related]
37. Effects of the Turkish subspecies of Viscum album on macrophage-derived cytokines.
Yesilada E; Deliorman D; Ergun F; Takaishi Y; Ono Y
J Ethnopharmacol; 1998 Jul; 61(3):195-200. PubMed ID: 9705010
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the effects of various clinically applied mistletoe preparations on peripheral blood leukocytes.
Elsässer-Beile U; Lusebrink S; Grussenmeyer T; Wetterauer U; Schultze-Seemann W
Arzneimittelforschung; 1998 Dec; 48(12):1185-9. PubMed ID: 9893935
[TBL] [Abstract][Full Text] [Related]
39. Immunomodulatory effects of iscador: a Viscum album preparation.
Hajto T
Oncology; 1986; 43 Suppl 1():51-65. PubMed ID: 2433654
[TBL] [Abstract][Full Text] [Related]
40. No evidence of IFN-gamma increase in the serum of HIV-positive and healthy subjects after subcutaneous injection of a non-fermented viscum album L. extract.
Stoss M; Gorter RW
Nat Immun; 1998; 16(4):157-64. PubMed ID: 10366786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
